Cancer treatment is moving toward a new era of precision. Instead of broadly activating the immune system, doctors are now exploring ways to precisely modulate it. This review looks at how targeting RNA processing works alongside immune checkpoint blockade to fight cancer.
The study points to clear synergistic effects when these two approaches are combined. Strategies that target mRNA processing, such as alternative splicing or RNA modifications, appear to work better when paired with existing immune therapies. This combination could help the body fight tumors more effectively than either method alone.
However, challenges remain. Off-target toxicity and the complex nature of tumors inside the body are hurdles researchers must overcome. Delivery technologies also need improvement to reach the right cells safely. While the potential is exciting, these strategies are still being tested in early-phase trials and preclinical models. The path forward requires careful navigation of these limitations to ensure patient safety.